- Alternative title
-
Sintomas incomuns da fase inicial da doença de Parkinson. Por que precisamos identificá-los?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Unusual early symptoms of Parkinson’s disease. Why do we need to identify them? ; volume:74 ; number:10 ; year:2016 ; pages:779-780
Arquivos de neuro-psiquiatria ; 74, Heft 10 (2016), 779-780
- Contributor
-
Ferraz, Henrique Ballalai
Silva, Carolina Candeias da
- DOI
-
10.1590/0004-282X20160135
- URN
-
urn:nbn:de:101:1-2023101912410405095659
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ferraz, Henrique Ballalai
- Silva, Carolina Candeias da
Other Objects (12)
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease